| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.0B | $11.9B | $11.3B | $11.6B | $10.0B | $2.2B | $2.3B | $1.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.9B | $5.3B | $4.9B | $4.9B | — | — | — | — |
| Net Income | $5.0B | $4.4B | $3.9B | $3.9B | $3.1B | $0.7B | $-0.6B | $0.4B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $43.0B | $37.5B | $36.5B | $35.7B | $35.5B | $36.4B | $40.4B | $22.8B |
| Current Assets | $4.0B | $3.3B | $2.8B | $1.9B | $1.5B | $1.5B | $1.5B | $0.9B |
| Cash & Equivalents | $2.1B | $1.5B | $1.0B | $0.2B | $0.0B | $0.0B | $0.0B | $0.1B |
| Total Liabilities | $28.5B | $23.5B | $22.9B | $22.2B | $22.5B | $22.4B | $22.8B | $14.9B |
| Current Liabilities | $3.2B | $3.2B | $2.6B | $2.4B | $3.3B | $2.1B | $2.1B | $1.2B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.9B | $5.9B | $5.4B | $5.0B | $4.9B | $4.5B | $4.1B | $2.8B |
| Investing Cash Flow | $-4.9B | $-2.0B | $-1.3B | $-1.0B | $-0.5B | $-1.3B | $-3.1B | $-2.7B |
| Capital Expenditures | $1.8B | $1.1B | $0.9B | $0.8B | $0.5B | $1.2B | $2.4B | $1.9B |
| Financing Cash Flow | $-0.4B | $-3.5B | $-3.3B | $-3.8B | $-4.4B | $-3.3B | $-1.1B | $-0.1B |